Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Denise Campagnolo"'
Autor:
Steven L. Galetta, Roumen Balabanov, Danette Rutledge, Roger Chang, Ray Su, Denise Campagnolo, Lily Lee, Laura J. Balcer, Jai Perumal, Robin Avila, Robert J. Fox
Publikováno v:
Advances in Therapy
Introduction STRIVE was a 4-year, multicenter, observational, open-label, single-arm study of natalizumab treatment in anti-JC virus antibody-negative (JCV-negative) relapsing-remitting multiple sclerosis (RRMS) patients with disease duration ≤ 3 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150c4d3589527c233f314a191e9be604
https://doi.org/10.1007/s12325-021-01722-w
https://doi.org/10.1007/s12325-021-01722-w
Autor:
Laura J. Balcer, Ray Su, Lily Lee, Jai Perumal, Roger Chang, Robert J. Fox, Robin Avila, Danette Rutledge, Denise Campagnolo, Roumen Balabanov, Steven L. Galetta
Publikováno v:
Advances in Therapy
STRIVE was a 4-year, multicenter, observational, open-label, single-arm study of natalizumab treatment in anti-JC virus antibody-negative (JCV-negative) relapsing-remitting multiple sclerosis (RRMS) patients with disease duration ≤ 3 years. The obj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a16f36cf59e1ec87131dc42feba5496
https://doi.org/10.1007/s12325-021-01815-6
https://doi.org/10.1007/s12325-021-01815-6
Autor:
James Williams, Carrie M. Hersh, Kathryn C. Fitzgerald, Marisa P. McGinley, Tjalf Ziemssen, Richard A. Rudick, Bernd C. Kieseier, Megan Hyland, Deborah M. Miller, Kuangnan Xiong, Denise Campagnolo, Irene Koulinska, Carl de Moor
Publikováno v:
Revue Neurologique. 177:S126
Introduction La qualite de vie (HRQoL) des patients SEP est inferieure a la population generale. Optimiser le traitement suppose comprendre les variations de HRQoL apres initiation du traitement de fond. Objectifs Evaluer les variations notees dans N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5303c31743a0dc3e79302975fa7f9350
https://doi.org/10.1016/j.neurol.2021.02.370
https://doi.org/10.1016/j.neurol.2021.02.370
Autor:
Richard A. Rudick, Kuangnan Xiong, Irene Koulinska, Megan Hyland, Deborah M. Miller, James Williams, Kathryn C. Fitzgerald, Marisa P. McGinley, Tjalf Ziemssen, Denise Campagnolo, Carl de Moor, Carrie M. Hersh, Bernd C. Kieseier
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background Optimizing multiple sclerosis treatment warrants understanding of changes in physical, mental, and social health. Objective To assess the impact of natalizumab on Quality of Life in Neurological Disorders (Neuro-QoL) scores. Methods Annual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da14662cb360dca2c7a147f9767e40e0
https://doi.org/10.1177/20552173211004634
https://doi.org/10.1177/20552173211004634
Publikováno v:
International Journal of MS Care. 18:230-238
Background: Physicians must weigh the benefits against the risk of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab, especially beyond 2 years. However, disability progression associated with switching therapies v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db0e3778d7ed7d9adda131ac90772267
https://doi.org/10.7224/1537-2073.2014-113
https://doi.org/10.7224/1537-2073.2014-113
Autor:
Tuula Tyry, Amber Salter, Denise Campagnolo, Genevieve A. Laforet, Robert J. Fox, Xiaojun You, Jennifer Sun
Publikováno v:
International Journal of MS Care. 15:194-201
Injectable first-line disease-modifying therapies (DMTs) for multiple sclerosis (MS) are generally prescribed for continuous use. Accordingly, the various factors that influence patient persistence with treatment and that can lead some patients to sw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b52d8e838efd83b9a166e2c33858245e
https://doi.org/10.7224/1537-2073.2012-034
https://doi.org/10.7224/1537-2073.2012-034
Autor:
Meghan Beier, Laura C. Schairer, Gary Cutter, Ruth Ann Marrie, Tuula Tyry, Eileen Farrell, Timothy Vollmer, Vance Zemon, Frederick W. Foley, Denise Campagnolo
Publikováno v:
Multiple Sclerosis Journal. 19:1197-1203
Background: Sexual dysfunction is common in multiple sclerosis (MS) but reliable and valid measurement in this population is needed. Objective: The objective of this research is to re-validate the Multiple Sclerosis Intimacy and Sexuality Questionnai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bebc069b0c8eb641fae5e387991be2b1
https://doi.org/10.1177/1352458512471876
https://doi.org/10.1177/1352458512471876
Publikováno v:
International journal of MS care. 18(5)
Background: Physicians must weigh the benefits against the risk of progressive multifocal leukoencephalopathy (PML) in patients treated with natalizumab, especially beyond 2 years. However, disability progression associated with switching therapies v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eb8f874251136b821136c732ccce1123
https://pubmed.ncbi.nlm.nih.gov/27803638
https://pubmed.ncbi.nlm.nih.gov/27803638
Publikováno v:
Journal of Neurovirology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::134b769823f85b83586b56cec9dfce98
https://pubmed.ncbi.nlm.nih.gov/27730447
https://pubmed.ncbi.nlm.nih.gov/27730447
Autor:
Ralph I. Horwitz, Tuula Tyry, Gary Cutter, Timothy Vollmer, Ruth-Ann Marrie, Denise Campagnolo
Publikováno v:
Neurology. 72:117-124
Background: Comorbidity is common in the general population and is associated with adverse health outcomes. In multiple sclerosis (MS), it is unknown whether preexisting comorbidity affects the delay between initial symptom onset and diagnosis (“di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fca8417a14d08eb014e2749ca360bfdb
https://doi.org/10.1212/01.wnl.0000333252.78173.5f
https://doi.org/10.1212/01.wnl.0000333252.78173.5f